Please login to the form below

Not currently logged in
Email:
Password:

Sanofi pasteur launches new €100m vaccine plant

Sanofi Pasteur has opened a new €100m vaccination production plant in France capable of rapid turned around to make immunisation drugs in the event of an influenza pandemic
Sanofi Pasteur has opened a new €100m vaccination production plant in France capable of rapid turned around to make immunisation drugs in the event of an influenza pandemic.

The company, which is a division of sanofi-aventis, says its inaugural production site in Val de Reuil is equipped with state-of-the-art automated technology and is designed to cope with the rising demand for vaccination medicines. Should the World Health Organisation (WHO) identify a pandemic of influenza, Sanofi Pasteur claims that the facility can be turned around to produce enough vaccines to meet the requirements of such an occurrence.

Wayne Pisano, president and CEO of Sanofi Pasteur, who opened the French production plant, said that the demand for vaccines will double by the year 2016.

"Sanofi Pasteur's commitment to global health is exemplified by significant investments in vaccine production infrastructures," he said.

"The new facility will provide a high-end production work environment for dedicated people who produce vaccines for the world."

Funding for this new site is set to boost the level of production to 200 million syringes filled and shipped ever year, a significant increase from the current level of two million vaccines per annum.

A further €100m is being spent on constructing a building in Val de Reuil for the formulation of vaccines. This forms part of a larger €600m investment programme initiated by the company in 2005. Pisano is confident that the new facilities will help the firm provide the global healthcare community with high quality vaccinations.

26th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics